Rank | Gene Set | Z-score |
---|---|---|
1 | phagocytosis, engulfment (GO:0006911) | 7.08650821 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 6.83237389 |
3 | Golgi transport vesicle coating (GO:0048200) | 6.83237389 |
4 | endocrine pancreas development (GO:0031018) | 6.55106656 |
5 | maintenance of gastrointestinal epithelium (GO:0030277) | 6.32565687 |
6 | serotonin receptor signaling pathway (GO:0007210) | 6.24614344 |
7 | regulation of respiratory burst (GO:0060263) | 6.10802793 |
8 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 6.05382841 |
9 | regulation of sarcomere organization (GO:0060297) | 5.79720645 |
10 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.65813805 |
11 | regulation of bile acid biosynthetic process (GO:0070857) | 5.60883096 |
12 | chemosensory behavior (GO:0007635) | 5.57370447 |
13 | hepatocyte differentiation (GO:0070365) | 5.48041494 |
14 | digestion (GO:0007586) | 5.40406872 |
15 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.38132245 |
16 | protein retention in ER lumen (GO:0006621) | 5.37273895 |
17 | regulation of mitochondrial translation (GO:0070129) | 5.28157862 |
18 | glandular epithelial cell differentiation (GO:0002067) | 5.27208224 |
19 | neurotransmitter catabolic process (GO:0042135) | 5.15381423 |
20 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 5.15164929 |
21 | regulation of phospholipase A2 activity (GO:0032429) | 5.13888886 |
22 | * positive regulation of insulin secretion (GO:0032024) | 5.05318301 |
23 | NAD biosynthetic process (GO:0009435) | 5.04240552 |
24 | epithelial structure maintenance (GO:0010669) | 4.95034514 |
25 | regulation of calcium ion import (GO:0090279) | 4.90147158 |
26 | protein autoprocessing (GO:0016540) | 4.83973337 |
27 | phenol-containing compound catabolic process (GO:0019336) | 4.83567295 |
28 | membrane invagination (GO:0010324) | 4.67018239 |
29 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.65521930 |
30 | viral entry into host cell (GO:0046718) | 4.58814237 |
31 | phenylpropanoid metabolic process (GO:0009698) | 4.51130668 |
32 | regulation of proton transport (GO:0010155) | 4.48354486 |
33 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.44704556 |
34 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 4.42866276 |
35 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.33032254 |
36 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.25456678 |
37 | L-fucose catabolic process (GO:0042355) | 4.25424912 |
38 | fucose catabolic process (GO:0019317) | 4.25424912 |
39 | L-fucose metabolic process (GO:0042354) | 4.25424912 |
40 | regulation of cellular extravasation (GO:0002691) | 4.18420404 |
41 | dentate gyrus development (GO:0021542) | 4.15346564 |
42 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 4.12373792 |
43 | pyridine nucleotide biosynthetic process (GO:0019363) | 4.12373792 |
44 | * positive regulation of peptide hormone secretion (GO:0090277) | 4.08853015 |
45 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.07624928 |
46 | * positive regulation of peptide secretion (GO:0002793) | 3.96441180 |
47 | primary alcohol catabolic process (GO:0034310) | 3.94130158 |
48 | venous blood vessel morphogenesis (GO:0048845) | 3.92902855 |
49 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.89474657 |
50 | intestinal epithelial cell development (GO:0060576) | 3.88945839 |
51 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.87406684 |
52 | mitochondrion transport along microtubule (GO:0047497) | 3.85340639 |
53 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.85340639 |
54 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.81411381 |
55 | angiogenesis involved in wound healing (GO:0060055) | 3.79919996 |
56 | DNA strand renaturation (GO:0000733) | 3.76784674 |
57 | iron ion import (GO:0097286) | 3.75269782 |
58 | lymphangiogenesis (GO:0001946) | 3.75157169 |
59 | * digestive system process (GO:0022600) | 3.74644873 |
60 | regulation of cardioblast proliferation (GO:0003264) | 3.72247747 |
61 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.72247747 |
62 | regulation of sulfur metabolic process (GO:0042762) | 3.71612138 |
63 | segment specification (GO:0007379) | 3.70666704 |
64 | response to cocaine (GO:0042220) | 3.66856332 |
65 | negative regulation of hormone metabolic process (GO:0032351) | 3.66686452 |
66 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.64833878 |
67 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.64833878 |
68 | positive regulation of glycolytic process (GO:0045821) | 3.62377823 |
69 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.61874628 |
70 | pH reduction (GO:0045851) | 3.59201681 |
71 | phosphatidylserine metabolic process (GO:0006658) | 3.58278872 |
72 | negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732) | 3.57222077 |
73 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.56937104 |
74 | pancreas development (GO:0031016) | 3.55071834 |
75 | glucose 6-phosphate metabolic process (GO:0051156) | 3.54842663 |
76 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.48230668 |
77 | acute-phase response (GO:0006953) | 3.47621864 |
78 | entry into cell of other organism involved in symbiotic interaction (GO:0051806) | 3.46286367 |
79 | entry into host (GO:0044409) | 3.46286367 |
80 | entry into other organism involved in symbiotic interaction (GO:0051828) | 3.46286367 |
81 | movement in host environment (GO:0052126) | 3.46286367 |
82 | entry into host cell (GO:0030260) | 3.46286367 |
83 | movement in environment of other organism involved in symbiotic interaction (GO:0052192) | 3.46286367 |
84 | fucose metabolic process (GO:0006004) | 3.44364859 |
85 | negative regulation of complement activation (GO:0045916) | 3.42552236 |
86 | sphingomyelin metabolic process (GO:0006684) | 3.41608299 |
87 | L-phenylalanine catabolic process (GO:0006559) | 3.41344905 |
88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.41344905 |
89 | endocardial cushion morphogenesis (GO:0003203) | 3.40725781 |
90 | epithelial cell fate commitment (GO:0072148) | 3.38957346 |
91 | establishment of mitochondrion localization (GO:0051654) | 3.37525923 |
92 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.36836610 |
93 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.35140659 |
94 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.35140659 |
95 | cardiac right ventricle morphogenesis (GO:0003215) | 3.31576130 |
96 | pyridine-containing compound biosynthetic process (GO:0072525) | 3.30826416 |
97 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.30412381 |
98 | L-phenylalanine metabolic process (GO:0006558) | 3.30412381 |
99 | positive regulation of protein homooligomerization (GO:0032464) | 3.30078221 |
100 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.29911069 |
101 | embryonic camera-type eye development (GO:0031076) | 3.29506753 |
102 | natural killer cell mediated immunity (GO:0002228) | 3.28845035 |
103 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.28845035 |
104 | sensory perception of smell (GO:0007608) | 3.27782508 |
105 | positive regulation of mitochondrial fission (GO:0090141) | 3.25783977 |
106 | negative regulation of protein kinase B signaling (GO:0051898) | 3.25756897 |
107 | ATP biosynthetic process (GO:0006754) | 3.23952794 |
108 | acute inflammatory response (GO:0002526) | 3.23811664 |
109 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.23751448 |
110 | epoxygenase P450 pathway (GO:0019373) | 3.23290628 |
111 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.22860724 |
112 | amino-acid betaine metabolic process (GO:0006577) | 3.19308224 |
113 | negative regulation of osteoclast differentiation (GO:0045671) | 3.19167177 |
114 | neuronal stem cell maintenance (GO:0097150) | 3.15705687 |
115 | ventricular septum morphogenesis (GO:0060412) | 3.14297754 |
116 | negative regulation of calcium ion transport (GO:0051926) | 3.11926028 |
117 | ectodermal placode formation (GO:0060788) | 3.11659714 |
118 | ethanol metabolic process (GO:0006067) | 3.09067773 |
119 | atrial septum morphogenesis (GO:0060413) | 3.09042565 |
120 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.08020027 |
121 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 3.07392880 |
122 | * regulation of insulin secretion (GO:0050796) | 3.07336592 |
123 | glutathione derivative biosynthetic process (GO:1901687) | 3.07035141 |
124 | glutathione derivative metabolic process (GO:1901685) | 3.07035141 |
125 | somite development (GO:0061053) | 3.06855041 |
126 | nephron tubule formation (GO:0072079) | 3.06230337 |
127 | anatomical structure regression (GO:0060033) | 3.06114318 |
128 | alditol phosphate metabolic process (GO:0052646) | 3.05208126 |
129 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.03879152 |
130 | peptide hormone processing (GO:0016486) | 3.03432991 |
131 | membrane budding (GO:0006900) | 3.03204176 |
132 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.02835488 |
133 | negative regulation of protein activation cascade (GO:2000258) | 3.02818817 |
134 | cardiac myofibril assembly (GO:0055003) | 3.01713756 |
135 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 3.01049187 |
136 | regulation of membrane lipid distribution (GO:0097035) | 3.00118334 |
137 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.98188317 |
138 | regulation of interleukin-8 secretion (GO:2000482) | 2.97818896 |
139 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.97792011 |
140 | innervation (GO:0060384) | 2.97450362 |
141 | sulfation (GO:0051923) | 2.96287847 |
142 | positive regulation of cell cycle checkpoint (GO:1901978) | 2.95923222 |
143 | response to BMP (GO:0071772) | 2.95916131 |
144 | cellular response to BMP stimulus (GO:0071773) | 2.95916131 |
145 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.94588368 |
146 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.92308572 |
147 | toxin metabolic process (GO:0009404) | 2.91368565 |
148 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.91196001 |
149 | inositol phosphate dephosphorylation (GO:0046855) | 2.91196001 |
150 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.91156327 |
151 | cerebellar granule cell differentiation (GO:0021707) | 2.91101609 |
152 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.87936653 |
153 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.87660964 |
154 | negative regulation of ion transmembrane transport (GO:0034766) | 2.87595822 |
155 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.87391403 |
156 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.87289942 |
157 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.87138170 |
158 | ATP synthesis coupled proton transport (GO:0015986) | 2.87138170 |
159 | import into cell (GO:0098657) | 2.86102032 |
160 | negative regulation of steroid biosynthetic process (GO:0010894) | 2.85268977 |
161 | O-glycan processing (GO:0016266) | 2.85025150 |
162 | negative regulation of humoral immune response (GO:0002921) | 2.84877653 |
163 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.84620324 |
164 | ER overload response (GO:0006983) | 2.84422328 |
165 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.83610846 |
166 | intestinal absorption (GO:0050892) | 2.82434352 |
167 | antibacterial humoral response (GO:0019731) | 2.81899446 |
168 | * regulation of peptide hormone secretion (GO:0090276) | 2.81629212 |
169 | neutrophil mediated immunity (GO:0002446) | 2.79913989 |
170 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.78810973 |
171 | gamma-aminobutyric acid transport (GO:0015812) | 2.77380649 |
172 | * regulation of peptide secretion (GO:0002791) | 2.76802621 |
173 | T-helper 1 type immune response (GO:0042088) | 2.73594982 |
174 | lipid particle organization (GO:0034389) | 2.73066604 |
175 | positive regulation of gastrulation (GO:2000543) | 2.72658055 |
176 | mucosal immune response (GO:0002385) | 2.71958000 |
177 | response to methylmercury (GO:0051597) | 2.70362382 |
178 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.69208008 |
179 | * positive regulation of hormone secretion (GO:0046887) | 2.69085699 |
180 | antimicrobial humoral response (GO:0019730) | 2.65602324 |
181 | phospholipid scrambling (GO:0017121) | 2.64561696 |
182 | response to gravity (GO:0009629) | 2.64216210 |
183 | regulation of beta-amyloid formation (GO:1902003) | 2.63138887 |
184 | nitric oxide biosynthetic process (GO:0006809) | 2.63019918 |
185 | cellular response to hexose stimulus (GO:0071331) | 2.62791636 |
186 | regulation of cardioblast differentiation (GO:0051890) | 2.62367780 |
187 | hydrogen ion transmembrane transport (GO:1902600) | 2.61442804 |
188 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.58386383 |
189 | atrioventricular valve morphogenesis (GO:0003181) | 2.58157045 |
190 | pharyngeal system development (GO:0060037) | 2.57555409 |
191 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.56451706 |
192 | regulation of acrosome reaction (GO:0060046) | 13.8411457 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.92012475 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.13775466 |
3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.05549002 |
4 | GATA1_22025678_ChIP-Seq_K562_Human | 4.00977032 |
5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.72258751 |
6 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.69659962 |
7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.68683230 |
8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.43072478 |
9 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.40346784 |
10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.30942330 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.23524672 |
12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.73144716 |
13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.72534412 |
14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.69244327 |
15 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.53648169 |
16 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.46886684 |
17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.33200177 |
18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.32466993 |
19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.30465063 |
20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.28301756 |
21 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.27856166 |
22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26794205 |
23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.16978276 |
24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.13994932 |
25 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 2.13590520 |
26 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.07649065 |
27 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.04458524 |
28 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02475512 |
29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.95564624 |
30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.90815669 |
31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87241198 |
32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.85808463 |
33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.85253342 |
34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.79728932 |
35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.75377995 |
36 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.74320724 |
37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.71828736 |
38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71160392 |
39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69740332 |
40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.69041600 |
41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.66988917 |
42 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.65289479 |
43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.63774149 |
44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.59652058 |
45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.55467707 |
46 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52958990 |
47 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.52958990 |
48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52553747 |
49 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.50158798 |
50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50027551 |
51 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48652120 |
52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.47530069 |
53 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.47414951 |
54 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.46905973 |
55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46873903 |
56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45059176 |
57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42471754 |
58 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.41819781 |
59 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.38634909 |
60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38244508 |
61 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.37920406 |
62 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36321758 |
63 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.35824317 |
64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35375530 |
65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35264519 |
66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34819385 |
67 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.32361877 |
68 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.31069526 |
69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28473402 |
70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28140009 |
71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27144743 |
72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27123214 |
73 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26858631 |
74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26050689 |
75 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25947455 |
76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25700827 |
77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25048442 |
78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22934705 |
79 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.22798961 |
80 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.21483500 |
81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21452886 |
82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21162439 |
83 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.20653681 |
84 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20189410 |
85 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16946325 |
86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16786672 |
87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16702416 |
88 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15426068 |
89 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15325988 |
90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14337324 |
91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14284049 |
92 | TBL1_22424771_ChIP-Seq_293T_Human | 1.14077761 |
93 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13953853 |
94 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13810567 |
95 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13676233 |
96 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.13223760 |
97 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.12654957 |
98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12380780 |
99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12090822 |
100 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11236827 |
101 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.10232670 |
102 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.10191907 |
103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08590043 |
104 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08310760 |
105 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07710705 |
106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07656213 |
107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07328700 |
108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06678205 |
109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06457624 |
110 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.05588524 |
111 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05332127 |
112 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.04608005 |
113 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03450706 |
114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.03301809 |
115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02848254 |
116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01497969 |
117 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.01110419 |
118 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00196916 |
119 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.00056050 |
120 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.00038556 |
121 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.99902008 |
122 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99772423 |
123 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99333383 |
124 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98914300 |
125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96886375 |
126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96693860 |
127 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.96325889 |
128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95968711 |
129 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95122214 |
130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94593543 |
131 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93682882 |
132 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.93638247 |
133 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93395320 |
134 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.93273121 |
135 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.92111640 |
136 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.91907598 |
137 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.91813039 |
138 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91609390 |
139 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90790977 |
140 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90790977 |
141 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90725295 |
142 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90344640 |
143 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89688003 |
144 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89571164 |
145 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.89421123 |
146 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.89366361 |
147 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.88887394 |
148 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88859073 |
149 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.88745896 |
150 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88567044 |
151 | AR_20517297_ChIP-Seq_VCAP_Human | 0.88493617 |
152 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88285561 |
153 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.88272611 |
154 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88150951 |
155 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87500271 |
156 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87239993 |
157 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87181320 |
158 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86668997 |
159 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86595639 |
160 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.86286280 |
161 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.83212888 |
162 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83048738 |
163 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.82018945 |
164 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80274684 |
165 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79208514 |
166 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79180213 |
167 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79018264 |
168 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.77905845 |
169 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.76787574 |
170 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.74999383 |
171 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.74372851 |
172 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.72331155 |
173 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71858949 |
174 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.71816313 |
175 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.71345472 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001666_abnormal_nutrient_absorption | 3.82190371 |
2 | MP0001664_abnormal_digestion | 3.58855500 |
3 | MP0002876_abnormal_thyroid_physiology | 3.55503227 |
4 | MP0001984_abnormal_olfaction | 3.40767302 |
5 | MP0004264_abnormal_extraembryonic_tissu | 3.37247620 |
6 | MP0000013_abnormal_adipose_tissue | 3.22556814 |
7 | MP0002735_abnormal_chemical_nociception | 3.21879689 |
8 | MP0010352_gastrointestinal_tract_polyps | 3.13291388 |
9 | MP0001873_stomach_inflammation | 2.90936065 |
10 | MP0000470_abnormal_stomach_morphology | 2.82701298 |
11 | MP0003195_calcinosis | 2.60180016 |
12 | MP0010368_abnormal_lymphatic_system | 2.59646205 |
13 | MP0003868_abnormal_feces_composition | 2.44634505 |
14 | MP0006054_spinal_hemorrhage | 2.37614014 |
15 | MP0003011_delayed_dark_adaptation | 2.34830659 |
16 | MP0003045_fibrosis | 2.33127618 |
17 | MP0005645_abnormal_hypothalamus_physiol | 2.31927880 |
18 | MP0010386_abnormal_urinary_bladder | 2.28218186 |
19 | MP0001944_abnormal_pancreas_morphology | 2.25983503 |
20 | MP0002928_abnormal_bile_duct | 2.25062441 |
21 | MP0005220_abnormal_exocrine_pancreas | 2.22861257 |
22 | MP0003806_abnormal_nucleotide_metabolis | 2.10273501 |
23 | MP0001501_abnormal_sleep_pattern | 2.09374982 |
24 | MP0002138_abnormal_hepatobiliary_system | 2.03665200 |
25 | MP0008004_abnormal_stomach_pH | 11.6638182 |
26 | MP0003123_paternal_imprinting | 1.93378158 |
27 | MP0001756_abnormal_urination | 1.86850541 |
28 | MP0005365_abnormal_bile_salt | 1.81509870 |
29 | MP0003787_abnormal_imprinting | 1.81347910 |
30 | MP0003959_abnormal_lean_body | 1.81318257 |
31 | MP0003183_abnormal_peptide_metabolism | 1.80700631 |
32 | MP0002332_abnormal_exercise_endurance | 1.77843077 |
33 | MP0003943_abnormal_hepatobiliary_system | 1.75691812 |
34 | MP0010234_abnormal_vibrissa_follicle | 1.72704837 |
35 | MP0000003_abnormal_adipose_tissue | 1.71996906 |
36 | MP0001851_eye_inflammation | 1.68769497 |
37 | * MP0002693_abnormal_pancreas_physiology | 1.68145399 |
38 | MP0002139_abnormal_hepatobiliary_system | 1.67977808 |
39 | MP0005083_abnormal_biliary_tract | 1.67868565 |
40 | MP0009780_abnormal_chondrocyte_physiolo | 1.67147376 |
41 | MP0005360_urolithiasis | 1.57447307 |
42 | MP0005257_abnormal_intraocular_pressure | 1.53011910 |
43 | MP0002909_abnormal_adrenal_gland | 1.50993058 |
44 | MP0003950_abnormal_plasma_membrane | 1.50509852 |
45 | MP0000427_abnormal_hair_cycle | 1.48190905 |
46 | MP0005085_abnormal_gallbladder_physiolo | 1.45849162 |
47 | MP0003724_increased_susceptibility_to | 1.44873714 |
48 | * MP0005266_abnormal_metabolism | 1.44224227 |
49 | MP0003329_amyloid_beta_deposits | 1.43905013 |
50 | * MP0002078_abnormal_glucose_homeostasis | 1.43522657 |
51 | MP0001905_abnormal_dopamine_level | 1.41870779 |
52 | MP0008961_abnormal_basal_metabolism | 1.39748124 |
53 | MP0003122_maternal_imprinting | 1.34876358 |
54 | MP0003566_abnormal_cell_adhesion | 1.34175894 |
55 | MP0004270_analgesia | 1.32088437 |
56 | MP0009764_decreased_sensitivity_to | 1.29430630 |
57 | MP0001440_abnormal_grooming_behavior | 1.27887783 |
58 | MP0000462_abnormal_digestive_system | 1.27412961 |
59 | MP0001663_abnormal_digestive_system | 1.25067346 |
60 | MP0006072_abnormal_retinal_apoptosis | 1.20079523 |
61 | MP0000538_abnormal_urinary_bladder | 1.19955185 |
62 | MP0001879_abnormal_lymphatic_vessel | 1.19849058 |
63 | MP0005023_abnormal_wound_healing | 1.17117867 |
64 | MP0010329_abnormal_lipoprotein_level | 1.16874104 |
65 | MP0003866_abnormal_defecation | 1.15660781 |
66 | MP0005187_abnormal_penis_morphology | 1.15358129 |
67 | MP0000534_abnormal_ureter_morphology | 1.14861526 |
68 | MP0004019_abnormal_vitamin_homeostasis | 1.14846888 |
69 | MP0000613_abnormal_salivary_gland | 1.12705123 |
70 | MP0005381_digestive/alimentary_phenotyp | 1.11899569 |
71 | MP0004510_myositis | 1.11374203 |
72 | MP0002168_other_aberrant_phenotype | 1.11064497 |
73 | MP0003119_abnormal_digestive_system | 1.10239137 |
74 | MP0004233_abnormal_muscle_weight | 1.09662244 |
75 | MP0000767_abnormal_smooth_muscle | 1.06890107 |
76 | MP0001348_abnormal_lacrimal_gland | 1.06730658 |
77 | MP0000477_abnormal_intestine_morphology | 1.05231020 |
78 | MP0002118_abnormal_lipid_homeostasis | 1.04923754 |
79 | MP0003300_gastrointestinal_ulcer | 1.01547478 |
80 | MP0009643_abnormal_urine_homeostasis | 1.00658922 |
81 | MP0002877_abnormal_melanocyte_morpholog | 0.99298076 |
82 | MP0005332_abnormal_amino_acid | 0.97408430 |
83 | * MP0003953_abnormal_hormone_level | 0.96666237 |
84 | MP0008569_lethality_at_weaning | 0.95703574 |
85 | MP0005084_abnormal_gallbladder_morpholo | 0.95399055 |
86 | MP0003385_abnormal_body_wall | 0.93860408 |
87 | MP0005334_abnormal_fat_pad | 0.91440604 |
88 | MP0005166_decreased_susceptibility_to | 0.88294347 |
89 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83546838 |
90 | MP0008872_abnormal_physiological_respon | 0.80048030 |
91 | MP0003252_abnormal_bile_duct | 0.79993746 |
92 | MP0000604_amyloidosis | 0.79624820 |
93 | MP0004883_abnormal_blood_vessel | 0.79622395 |
94 | MP0004885_abnormal_endolymph | 0.79358661 |
95 | MP0002837_dystrophic_cardiac_calcinosis | 0.78607923 |
96 | MP0001881_abnormal_mammary_gland | 0.77869916 |
97 | * MP0005376_homeostasis/metabolism_phenot | 0.76930244 |
98 | MP0003137_abnormal_impulse_conducting | 0.76393214 |
99 | MP0005165_increased_susceptibility_to | 0.74982810 |
100 | MP0002089_abnormal_postnatal_growth/wei | 0.74859183 |
101 | MP0010155_abnormal_intestine_physiology | 0.74712674 |
102 | MP0005448_abnormal_energy_balance | 0.74389805 |
103 | * MP0005452_abnormal_adipose_tissue | 0.72906545 |
104 | MP0001970_abnormal_pain_threshold | 0.72474032 |
105 | MP0000465_gastrointestinal_hemorrhage | 0.72043316 |
106 | MP0005164_abnormal_response_to | 0.69205942 |
107 | MP0005310_abnormal_salivary_gland | 0.68940972 |
108 | MP0009384_cardiac_valve_regurgitation | 0.68416705 |
109 | MP0002751_abnormal_autonomic_nervous | 0.68364884 |
110 | MP0000377_abnormal_hair_follicle | 0.67690884 |
111 | MP0001765_abnormal_ion_homeostasis | 0.67570470 |
112 | MP0003633_abnormal_nervous_system | 0.67142788 |
113 | MP0000343_altered_response_to | 0.66828766 |
114 | MP0001853_heart_inflammation | 0.66429225 |
115 | MP0002148_abnormal_hypersensitivity_rea | 0.64754169 |
116 | MP0002896_abnormal_bone_mineralization | 0.64527840 |
117 | MP0001845_abnormal_inflammatory_respons | 0.64511447 |
118 | MP0003121_genomic_imprinting | 0.62133098 |
119 | MP0005408_hypopigmentation | 0.61114754 |
120 | MP0005319_abnormal_enzyme/_coenzyme | 0.60785641 |
121 | MP0003186_abnormal_redox_activity | 0.59944505 |
122 | MP0005058_abnormal_lysosome_morphology | 0.58612050 |
123 | MP0002970_abnormal_white_adipose | 0.58257578 |
124 | MP0005501_abnormal_skin_physiology | 0.57359574 |
125 | MP0009785_altered_susceptibility_to | 0.56271342 |
126 | MP0000537_abnormal_urethra_morphology | 0.55543019 |
127 | MP0005375_adipose_tissue_phenotype | 0.55064521 |
128 | MP0000639_abnormal_adrenal_gland | 0.53385488 |
129 | MP0004742_abnormal_vestibular_system | 0.52960849 |
130 | MP0002136_abnormal_kidney_physiology | 0.52570507 |
131 | * MP0009642_abnormal_blood_homeostasis | 0.52050754 |
132 | MP0003283_abnormal_digestive_organ | 0.51318401 |
133 | MP0004043_abnormal_pH_regulation | 0.50616768 |
134 | MP0000609_abnormal_liver_physiology | 0.50335185 |
135 | MP0003936_abnormal_reproductive_system | 0.50275523 |
136 | MP0002166_altered_tumor_susceptibility | 0.50249793 |
137 | MP0000490_abnormal_crypts_of | 0.50024001 |
138 | MP0005636_abnormal_mineral_homeostasis | 0.48809289 |
139 | MP0001485_abnormal_pinna_reflex | 0.48501166 |
140 | MP0004947_skin_inflammation | 0.48448646 |
141 | * MP0002069_abnormal_eating/drinking_beha | 0.48142595 |
142 | MP0005395_other_phenotype | 0.47753511 |
143 | MP0009703_decreased_birth_body | 0.45526295 |
144 | MP0002796_impaired_skin_barrier | 0.45291281 |
145 | MP0002419_abnormal_innate_immunity | 0.43982361 |
146 | MP0001216_abnormal_epidermal_layer | 0.43206392 |
147 | MP0009765_abnormal_xenobiotic_induced | 0.43156763 |
148 | MP0001915_intracranial_hemorrhage | 0.43113389 |
149 | MP0001784_abnormal_fluid_regulation | 0.42721867 |
150 | MP0000467_abnormal_esophagus_morphology | 0.42315567 |
151 | MP0005410_abnormal_fertilization | 0.40642549 |
152 | MP0009840_abnormal_foam_cell | 0.40477650 |
153 | MP0009115_abnormal_fat_cell | 0.39962615 |
154 | MP0001145_abnormal_male_reproductive | 0.39921169 |
155 | MP0003638_abnormal_response/metabolism_ | 0.37981952 |
156 | MP0000653_abnormal_sex_gland | 0.37448783 |
157 | MP0000955_abnormal_spinal_cord | 0.37417419 |
158 | MP0000598_abnormal_liver_morphology | 0.36497429 |
159 | MP0003631_nervous_system_phenotype | 0.35435104 |
160 | MP0002938_white_spotting | 0.34466455 |
161 | MP0009672_abnormal_birth_weight | 0.33675329 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Steatorrhea (HP:0002570) | 9.28304348 |
2 | Exocrine pancreatic insufficiency (HP:0001738) | 9.27711794 |
3 | Hypoglycemic coma (HP:0001325) | 8.64286100 |
4 | Hypoglycemic seizures (HP:0002173) | 8.51269177 |
5 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.97508702 |
6 | Hyperglycemia (HP:0003074) | 7.34620877 |
7 | Ketoacidosis (HP:0001993) | 7.15446743 |
8 | Fat malabsorption (HP:0002630) | 7.14785991 |
9 | Abnormality of endocrine pancreas physiology (HP:0012093) | 6.74312582 |
10 | Abnormality of the pancreatic islet cells (HP:0006476) | 6.74312582 |
11 | Symptomatic seizures (HP:0011145) | 6.62729247 |
12 | Late onset (HP:0003584) | 6.22370286 |
13 | Tubulointerstitial nephritis (HP:0001970) | 5.89174322 |
14 | Abnormal number of erythroid precursors (HP:0012131) | 5.73831014 |
15 | Pancreatic islet-cell hyperplasia (HP:0004510) | 5.58224385 |
16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.03052492 |
17 | Broad distal phalanx of finger (HP:0009836) | 4.79559633 |
18 | Ketosis (HP:0001946) | 4.56958557 |
19 | Tubulointerstitial abnormality (HP:0001969) | 4.50172849 |
20 | Unilateral renal agenesis (HP:0000122) | 4.32755617 |
21 | Hepatocellular carcinoma (HP:0001402) | 4.25281537 |
22 | Epidermoid cyst (HP:0200040) | 4.20714041 |
23 | Bilateral sensorineural hearing impairment (HP:0008619) | 4.16615683 |
24 | Abnormality of vitamin B metabolism (HP:0004340) | 4.12768669 |
25 | Enlarged kidneys (HP:0000105) | 4.06722166 |
26 | 3-Methylglutaconic aciduria (HP:0003535) | 4.03125909 |
27 | Obstructive lung disease (HP:0006536) | 4.02518329 |
28 | Chronic obstructive pulmonary disease (HP:0006510) | 4.02518329 |
29 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.95973943 |
30 | Toxemia of pregnancy (HP:0100603) | 3.92445339 |
31 | Hypoproteinemia (HP:0003075) | 3.87660743 |
32 | Febrile seizures (HP:0002373) | 3.81431515 |
33 | Abnormality of vitamin metabolism (HP:0100508) | 3.77952733 |
34 | Hypercortisolism (HP:0001578) | 3.74262642 |
35 | Pancreatitis (HP:0001733) | 3.61755220 |
36 | Megaloblastic anemia (HP:0001889) | 3.61617805 |
37 | Abnormality of the renal cortex (HP:0011035) | 3.59499120 |
38 | Facial shape deformation (HP:0011334) | 3.52563731 |
39 | Potter facies (HP:0002009) | 3.52563731 |
40 | Microvesicular hepatic steatosis (HP:0001414) | 3.46573895 |
41 | Fatigue (HP:0012378) | 3.45238856 |
42 | Xanthomatosis (HP:0000991) | 3.43475145 |
43 | Severe muscular hypotonia (HP:0006829) | 3.40402927 |
44 | Lipid accumulation in hepatocytes (HP:0006561) | 3.37284993 |
45 | Hemiparesis (HP:0001269) | 3.33786810 |
46 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.33599356 |
47 | Abnormality of the pleura (HP:0002103) | 3.32767340 |
48 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.29049391 |
49 | Tubulointerstitial fibrosis (HP:0005576) | 3.27959735 |
50 | Insulin resistance (HP:0000855) | 3.22954604 |
51 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.22755750 |
52 | Villous atrophy (HP:0011473) | 3.22755750 |
53 | Increased hepatocellular lipid droplets (HP:0006565) | 3.22722481 |
54 | Neonatal death (HP:0003811) | 3.19897682 |
55 | Pheochromocytoma (HP:0002666) | 3.19611672 |
56 | Pancreatic cysts (HP:0001737) | 3.13873167 |
57 | Right ventricular cardiomyopathy (HP:0011663) | 3.10532672 |
58 | Abnormal pancreas size (HP:0012094) | 3.10131300 |
59 | Sensory axonal neuropathy (HP:0003390) | 3.06457561 |
60 | Erythema (HP:0010783) | 3.05196859 |
61 | Growth hormone excess (HP:0000845) | 3.00895681 |
62 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.98898698 |
63 | Emphysema (HP:0002097) | 2.95441077 |
64 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.89596753 |
65 | Hip dysplasia (HP:0001385) | 2.89434635 |
66 | Gout (HP:0001997) | 2.87389662 |
67 | Large for gestational age (HP:0001520) | 2.87227210 |
68 | Abnormality of dentin (HP:0010299) | 2.86933649 |
69 | Prominent metopic ridge (HP:0005487) | 2.79244360 |
70 | Macroorchidism (HP:0000053) | 2.77563089 |
71 | Agitation (HP:0000713) | 2.75783506 |
72 | Abdominal distention (HP:0003270) | 2.75316208 |
73 | Generalized myoclonic seizures (HP:0002123) | 2.71048351 |
74 | Neurofibrillary tangles (HP:0002185) | 2.69002618 |
75 | Congenital sensorineural hearing impairment (HP:0008527) | 2.67525486 |
76 | Tapered finger (HP:0001182) | 2.66185160 |
77 | Ventricular fibrillation (HP:0001663) | 2.62568274 |
78 | Hyperparathyroidism (HP:0000843) | 2.61699926 |
79 | Neuroendocrine neoplasm (HP:0100634) | 2.56252915 |
80 | Vacuolated lymphocytes (HP:0001922) | 2.56153703 |
81 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.55399149 |
82 | Hypsarrhythmia (HP:0002521) | 2.54262061 |
83 | Dysostosis multiplex (HP:0000943) | 2.52674115 |
84 | EEG with generalized epileptiform discharges (HP:0011198) | 2.52221522 |
85 | Glucose intolerance (HP:0000833) | 2.50994920 |
86 | Syncope (HP:0001279) | 2.50695671 |
87 | Cystic liver disease (HP:0006706) | 2.43896442 |
88 | Enlarged penis (HP:0000040) | 2.42761633 |
89 | Tachypnea (HP:0002789) | 2.42247816 |
90 | Epileptiform EEG discharges (HP:0011182) | 2.41933867 |
91 | Severe Myopia (HP:0011003) | 2.41440988 |
92 | Esophageal varix (HP:0002040) | 2.37800730 |
93 | Glycosuria (HP:0003076) | 2.35273057 |
94 | Abnormality of urine glucose concentration (HP:0011016) | 2.35273057 |
95 | Portal hypertension (HP:0001409) | 2.32216804 |
96 | Testicular neoplasm (HP:0010788) | 2.31702116 |
97 | Congenital hepatic fibrosis (HP:0002612) | 2.29953865 |
98 | Abnormality of the dental root (HP:0006486) | 2.28999041 |
99 | Taurodontia (HP:0000679) | 2.28999041 |
100 | Abnormality of permanent molar morphology (HP:0011071) | 2.28999041 |
101 | Abnormality of the metopic suture (HP:0005556) | 2.26540330 |
102 | Double outlet right ventricle (HP:0001719) | 2.23198347 |
103 | Congenital malformation of the right heart (HP:0011723) | 2.23198347 |
104 | Posterior subcapsular cataract (HP:0007787) | 2.22466109 |
105 | Cerebral inclusion bodies (HP:0100314) | 2.22363733 |
106 | Epileptic encephalopathy (HP:0200134) | 2.21047664 |
107 | Impulsivity (HP:0100710) | 2.18815351 |
108 | Cerebral aneurysm (HP:0004944) | 2.17458216 |
109 | Abnormality of molar morphology (HP:0011070) | 2.17115809 |
110 | Abnormality of molar (HP:0011077) | 2.17115809 |
111 | Abnormality of the hepatic vasculature (HP:0006707) | 2.14295681 |
112 | Type II diabetes mellitus (HP:0005978) | 2.12305046 |
113 | Sex reversal (HP:0012245) | 2.10265620 |
114 | Abnormal sex determination (HP:0012244) | 2.10265620 |
115 | Palpitations (HP:0001962) | 2.08110219 |
116 | Renal hypoplasia (HP:0000089) | 2.06938176 |
117 | Bulbous nose (HP:0000414) | 2.05240830 |
118 | Abnormality of the dental pulp (HP:0006479) | 2.04881135 |
119 | Abnormality of the renal medulla (HP:0100957) | 2.04465927 |
120 | Dyskinesia (HP:0100660) | 2.04354617 |
121 | Postural tremor (HP:0002174) | 2.00168320 |
122 | Dysmetric saccades (HP:0000641) | 1.99754333 |
123 | Hypoalphalipoproteinemia (HP:0003233) | 1.96689031 |
124 | Hyperlipoproteinemia (HP:0010980) | 1.96685628 |
125 | Hyperphosphatemia (HP:0002905) | 1.96192571 |
126 | Adrenal overactivity (HP:0002717) | 1.94909056 |
127 | Hypoplastic ischia (HP:0003175) | 1.93641424 |
128 | Goiter (HP:0000853) | 1.93484224 |
129 | Hypoplastic ilia (HP:0000946) | 1.92951786 |
130 | Scanning speech (HP:0002168) | 1.91838463 |
131 | Retinal atrophy (HP:0001105) | 1.90575372 |
132 | Hypoplasia of the uterus (HP:0000013) | 1.86466148 |
133 | Easy fatigability (HP:0003388) | 1.85990809 |
134 | Neoplasm of the liver (HP:0002896) | 1.85750261 |
135 | Cerebral hemorrhage (HP:0001342) | 1.85357855 |
136 | Oligodactyly (hands) (HP:0001180) | 1.83417142 |
137 | Focal seizures (HP:0007359) | 1.81792021 |
138 | Pathologic fracture (HP:0002756) | 1.81460478 |
139 | Abnormality of the sella turcica (HP:0002679) | 1.80916352 |
140 | Restlessness (HP:0000711) | 1.80030840 |
141 | Congenital glaucoma (HP:0001087) | 1.79171097 |
142 | Short thorax (HP:0010306) | 1.78096543 |
143 | Abnormality of the fingertips (HP:0001211) | 1.77753152 |
144 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77415562 |
145 | Skin nodule (HP:0200036) | 1.76466500 |
146 | Tetraplegia (HP:0002445) | 1.74031485 |
147 | Dysautonomia (HP:0002459) | 1.73129449 |
148 | Parakeratosis (HP:0001036) | 1.73095842 |
149 | Microretrognathia (HP:0000308) | 1.71487713 |
150 | Increased IgM level (HP:0003496) | 1.71364082 |
151 | Neoplasm of the adrenal gland (HP:0100631) | 1.70650898 |
152 | Downturned corners of mouth (HP:0002714) | 1.69207585 |
153 | Disproportionate short-trunk short stature (HP:0003521) | 1.69141401 |
154 | Abnormality of the ischium (HP:0003174) | 1.69043446 |
155 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.68813690 |
156 | Stage 5 chronic kidney disease (HP:0003774) | 1.68761381 |
157 | Generalized hyperpigmentation (HP:0007440) | 1.68503072 |
158 | Abnormality of the neuromuscular junction (HP:0003398) | 1.68210029 |
159 | Fatigable weakness (HP:0003473) | 1.68210029 |
160 | Orthostatic hypotension (HP:0001278) | 1.67849893 |
161 | Nephrotic syndrome (HP:0000100) | 1.67027101 |
162 | Status epilepticus (HP:0002133) | 1.67023252 |
163 | Barrel-shaped chest (HP:0001552) | 1.66563057 |
164 | Neoplasm of the pancreas (HP:0002894) | 1.64907584 |
165 | Cheilitis (HP:0100825) | 1.64105709 |
166 | Fragile skin (HP:0001030) | 1.61640375 |
167 | Spondylolisthesis (HP:0003302) | 1.61342909 |
168 | Menstrual irregularities (HP:0000858) | 1.60060709 |
169 | Proximal tubulopathy (HP:0000114) | 1.58298167 |
170 | Ankyloglossia (HP:0010296) | 1.55325727 |
171 | Micronodular cirrhosis (HP:0001413) | 1.54915973 |
172 | Conjunctival hamartoma (HP:0100780) | 1.54179482 |
173 | Broad face (HP:0000283) | 1.53283169 |
174 | Irritability (HP:0000737) | 1.53233206 |
175 | Intrahepatic cholestasis (HP:0001406) | 1.51329436 |
176 | Increased CSF protein (HP:0002922) | 1.50730693 |
177 | Cardiomegaly (HP:0001640) | 1.50224376 |
178 | Abnormality of the gastric mucosa (HP:0004295) | 1.47360250 |
179 | Hoarse voice (HP:0001609) | 1.47206502 |
180 | Mask-like facies (HP:0000298) | 1.43917432 |
181 | Curly hair (HP:0002212) | 1.43162235 |
182 | Prolonged QT interval (HP:0001657) | 1.42788403 |
183 | Striae distensae (HP:0001065) | 1.42627023 |
184 | Thin bony cortex (HP:0002753) | 1.41214229 |
185 | Hand muscle atrophy (HP:0009130) | 1.40961124 |
186 | Peripheral demyelination (HP:0011096) | 1.40376184 |
187 | Progressive sensorineural hearing impairment (HP:0000408) | 1.39342775 |
188 | Abnormality of oral frenula (HP:0000190) | 1.38798352 |
189 | Hypotension (HP:0002615) | 1.34339669 |
190 | Hypoplasia of dental enamel (HP:0006297) | 1.34220867 |
191 | Abnormality of purine metabolism (HP:0004352) | 1.34155716 |
192 | Slender long bone (HP:0003100) | 1.33437140 |
193 | Bone cyst (HP:0012062) | 1.32991457 |
194 | Abnormal biliary tract morphology (HP:0012440) | 1.32600277 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK24 | 7.41333959 |
2 | EPHA2 | 6.23201448 |
3 | PIK3CG | 5.55034996 |
4 | WNK3 | 5.28736855 |
5 | MAPK15 | 4.95612706 |
6 | STK38L | 4.43032740 |
7 | CDK19 | 3.62251225 |
8 | INSRR | 3.57405530 |
9 | MAP3K4 | 3.34032981 |
10 | NME1 | 2.67006483 |
11 | BMPR1B | 2.63484504 |
12 | BCKDK | 2.10154906 |
13 | FGR | 2.05861915 |
14 | MST4 | 2.00820353 |
15 | EPHA3 | 1.96273128 |
16 | KSR2 | 1.89327624 |
17 | MAP2K7 | 1.88576455 |
18 | MAP2K2 | 1.80488729 |
19 | MST1R | 1.80340723 |
20 | MAP3K2 | 1.77921692 |
21 | MAP3K12 | 1.73666079 |
22 | MYLK | 1.69598454 |
23 | TESK1 | 1.68418602 |
24 | DYRK1B | 1.67968468 |
25 | PTK6 | 1.67544477 |
26 | SIK3 | 1.53634220 |
27 | PAK3 | 1.52556251 |
28 | MET | 1.47219557 |
29 | FER | 1.46535165 |
30 | TGFBR2 | 1.46478296 |
31 | RIPK1 | 1.41726756 |
32 | NTRK3 | 1.36734693 |
33 | WNK4 | 1.34860791 |
34 | PTK2 | 1.34467406 |
35 | BRD4 | 1.32410482 |
36 | CAMK1G | 1.26239175 |
37 | ADRBK2 | 1.18627313 |
38 | NTRK1 | 1.17082103 |
39 | FGFR4 | 1.17074325 |
40 | PKN2 | 1.17027245 |
41 | CDK8 | 1.13517365 |
42 | IRAK1 | 1.11170053 |
43 | ERN1 | 1.10440779 |
44 | MAP2K4 | 1.08262044 |
45 | CDC42BPA | 1.06582757 |
46 | GRK1 | 1.06535537 |
47 | STK3 | 1.05840110 |
48 | UHMK1 | 1.05802357 |
49 | HIPK2 | 1.05391859 |
50 | PRKG2 | 1.02237282 |
51 | TGFBR1 | 1.01625037 |
52 | OXSR1 | 0.99439678 |
53 | ILK | 0.99096478 |
54 | TAOK3 | 0.98774569 |
55 | PIM2 | 0.98436519 |
56 | PRKCI | 0.97441108 |
57 | LRRK2 | 0.97333588 |
58 | RIPK4 | 0.96326751 |
59 | DAPK1 | 0.92614440 |
60 | MAP2K1 | 0.92295490 |
61 | CAMK1D | 0.89948381 |
62 | PAK4 | 0.86919137 |
63 | TYK2 | 0.85754931 |
64 | TRIB3 | 0.81876317 |
65 | SMG1 | 0.80525773 |
66 | SIK2 | 0.80492682 |
67 | CSNK1A1L | 0.79509593 |
68 | STK38 | 0.79031079 |
69 | CSNK1G2 | 0.77235723 |
70 | MAP3K9 | 0.76541796 |
71 | CSNK1G3 | 0.76152151 |
72 | MAP2K6 | 0.72158883 |
73 | FRK | 0.71917173 |
74 | DAPK3 | 0.71202823 |
75 | SIK1 | 0.70845813 |
76 | ARAF | 0.69294859 |
77 | LMTK2 | 0.68488273 |
78 | ERBB3 | 0.67124809 |
79 | CLK1 | 0.66526447 |
80 | RAF1 | 0.65992799 |
81 | ERBB4 | 0.65438194 |
82 | BMPR2 | 0.63334830 |
83 | LIMK1 | 0.62726813 |
84 | NUAK1 | 0.62550110 |
85 | TBK1 | 0.62043915 |
86 | CAMK2D | 0.60394759 |
87 | NLK | 0.60245480 |
88 | MARK3 | 0.59943303 |
89 | STK39 | 0.59742686 |
90 | CSNK1G1 | 0.59370065 |
91 | DAPK2 | 0.57341229 |
92 | WNK1 | 0.55013710 |
93 | CHUK | 0.54085349 |
94 | RPS6KA2 | 0.51577868 |
95 | KSR1 | 0.50861855 |
96 | FGFR1 | 0.49564805 |
97 | CASK | 0.48033195 |
98 | MAP3K8 | 0.47598122 |
99 | EPHB2 | 0.46807794 |
100 | EPHB1 | 0.46537912 |
101 | MARK2 | 0.45550935 |
102 | DYRK1A | 0.44539697 |
103 | DYRK2 | 0.44249957 |
104 | FLT3 | 0.44037031 |
105 | MKNK2 | 0.42105696 |
106 | PDGFRB | 0.42011623 |
107 | MAPK11 | 0.40061997 |
108 | TNK2 | 0.39427360 |
109 | ROCK2 | 0.38864032 |
110 | DMPK | 0.37608735 |
111 | FGFR3 | 0.37069743 |
112 | JAK1 | 0.36650919 |
113 | CDK9 | 0.36431550 |
114 | RET | 0.36143827 |
115 | CSK | 0.35172258 |
116 | MTOR | 0.33923929 |
117 | GRK7 | 0.32974721 |
118 | CAMK2B | 0.32716934 |
119 | PNCK | 0.32447230 |
120 | SRC | 0.32104605 |
121 | TTN | 0.31374857 |
122 | CDK6 | 0.31034437 |
123 | CDK5 | 0.30600832 |
124 | EPHA4 | 0.29848107 |
125 | MELK | 0.29696759 |
126 | ERBB2 | 0.27434536 |
127 | PTK2B | 0.26921914 |
128 | NEK6 | 0.26043703 |
129 | FYN | 0.25476696 |
130 | CAMK2G | 0.25453537 |
131 | JAK2 | 0.25163284 |
132 | STK4 | 0.24167938 |
133 | PIK3CA | 0.23339001 |
134 | CDK11A | 0.22961160 |
135 | PAK2 | 0.22682994 |
136 | CDK14 | 0.22274060 |
137 | ROCK1 | 0.22249977 |
138 | CAMK1 | 0.21854770 |
139 | GRK6 | 0.21656868 |
140 | PDPK1 | 0.21316980 |
141 | ZAP70 | 0.20722383 |
142 | RPS6KA6 | 0.20627341 |
143 | MAP3K11 | 0.20492251 |
144 | STK10 | 0.18942472 |
145 | RPS6KA1 | 0.18840691 |
146 | PRKCQ | 0.18828152 |
147 | RPS6KC1 | 0.18784427 |
148 | RPS6KL1 | 0.18784427 |
149 | EIF2AK1 | 0.18156385 |
150 | CAMK2A | 0.16830280 |
151 | MAPK7 | 0.14812082 |
152 | RPS6KA5 | 0.13047851 |
153 | CSNK1D | 0.12471695 |
154 | ACVR1B | 0.11784109 |
155 | CSNK1A1 | 0.11068153 |
156 | PRKCE | 0.07189828 |
157 | PRKAA2 | 0.05596661 |
158 | PHKG1 | 0.05067898 |
159 | PHKG2 | 0.05067898 |
160 | GRK5 | 0.04964020 |
161 | MAP3K1 | 0.04170173 |
162 | ALK | 0.04000703 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.99459153 |
2 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 5.04109899 |
3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 4.33474160 |
4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.91408123 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 3.46240419 |
6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.38578666 |
7 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.34106665 |
8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.17953079 |
9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.09476795 |
10 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 3.01434851 |
11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.83009105 |
12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.70372484 |
13 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.68256460 |
14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.42311994 |
15 | Taste transduction_Homo sapiens_hsa04742 | 2.29621170 |
16 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.23876872 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 2.02497473 |
18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.99921695 |
19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.93957660 |
20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.90325238 |
21 | Homologous recombination_Homo sapiens_hsa03440 | 1.81140362 |
22 | Salmonella infection_Homo sapiens_hsa05132 | 1.79251554 |
23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76397054 |
24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.73677647 |
25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.73568254 |
26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.68475458 |
27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67336512 |
28 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.65148876 |
29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57763514 |
30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.56804045 |
31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.53033296 |
32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.47314699 |
33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.43029514 |
34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.42664675 |
35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37708063 |
36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35472732 |
37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29846073 |
38 | Adherens junction_Homo sapiens_hsa04520 | 1.29469850 |
39 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14952158 |
40 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14480646 |
41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13895081 |
42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13492657 |
43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11923412 |
44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11301932 |
45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10568263 |
46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.07481591 |
47 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.00756562 |
48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00316343 |
49 | Parkinsons disease_Homo sapiens_hsa05012 | 0.99058585 |
50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98205883 |
51 | Protein export_Homo sapiens_hsa03060 | 0.95645887 |
52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94930352 |
53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93661699 |
54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89938964 |
55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89402836 |
56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89332053 |
57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87466592 |
58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87219558 |
59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85515782 |
60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85424063 |
61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83813418 |
62 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.82882008 |
63 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82611475 |
64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81516097 |
65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78531725 |
66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77540614 |
67 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.74988282 |
68 | ABC transporters_Homo sapiens_hsa02010 | 0.73858977 |
69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73774148 |
70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73527702 |
71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73458402 |
72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71218647 |
73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70195656 |
74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69004365 |
75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.68151950 |
76 | Tight junction_Homo sapiens_hsa04530 | 0.65885825 |
77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65828548 |
78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65579108 |
79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65537824 |
80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65487960 |
81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64350214 |
82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63115801 |
83 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60604035 |
84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59947483 |
85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59402754 |
86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.59231922 |
87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58323071 |
88 | Peroxisome_Homo sapiens_hsa04146 | 0.57749598 |
89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57315179 |
90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56226098 |
91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56084649 |
92 | Bladder cancer_Homo sapiens_hsa05219 | 0.53514181 |
93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52581586 |
94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50516706 |
95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49841928 |
96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49627704 |
97 | Bile secretion_Homo sapiens_hsa04976 | 0.47763261 |
98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46966918 |
99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46849768 |
100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46849413 |
101 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46787217 |
102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46562937 |
103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46117137 |
104 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45648680 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.42086865 |
106 | Melanoma_Homo sapiens_hsa05218 | 0.41898240 |
107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39814349 |
108 | Renin secretion_Homo sapiens_hsa04924 | 0.39083786 |
109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39015530 |
110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.37216591 |
111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34255071 |
112 | Lysosome_Homo sapiens_hsa04142 | 0.33832170 |
113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33814625 |
114 | Insulin resistance_Homo sapiens_hsa04931 | 0.33611208 |
115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33131327 |
116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32303271 |
117 | Measles_Homo sapiens_hsa05162 | 0.32239197 |
118 | Pertussis_Homo sapiens_hsa05133 | 0.32224604 |
119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31854254 |
120 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.31807442 |
121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31708613 |
122 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.30255702 |
123 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.29592511 |
124 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.29527418 |
125 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28569118 |
126 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28420193 |
127 | Prion diseases_Homo sapiens_hsa05020 | 0.28388990 |
128 | Mineral absorption_Homo sapiens_hsa04978 | 0.27619828 |
129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27208141 |
130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.26676616 |
131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26486332 |
132 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.25775440 |
133 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25006634 |
134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.24946638 |
135 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24780561 |
136 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.24684616 |
137 | Shigellosis_Homo sapiens_hsa05131 | 0.24263167 |
138 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24034717 |
139 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23860297 |
140 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.23344624 |
141 | Leishmaniasis_Homo sapiens_hsa05140 | 0.22923990 |
142 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22715475 |
143 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22323092 |
144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22208270 |
145 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.21463132 |
146 | Hepatitis C_Homo sapiens_hsa05160 | 0.21277564 |
147 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20904151 |
148 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20473139 |
149 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.20293951 |
150 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.19588535 |
151 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.19029554 |
152 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.18421587 |
153 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17270662 |
154 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.16850543 |
155 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.16561933 |
156 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.16332890 |
157 | Phagosome_Homo sapiens_hsa04145 | 0.16009813 |
158 | Lysine degradation_Homo sapiens_hsa00310 | 0.15409848 |
159 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14709301 |
160 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13921540 |